scholarly article | Q13442814 |
P356 | DOI | 10.24272/J.ISSN.2095-8137.2017.015 |
P724 | Internet Archive ID | zoological-research-2095-8137-3794 |
P932 | PMC publication ID | 5396031 |
P698 | PubMed publication ID | 28409504 |
P2093 | author name string | Yang Wu | |
Xin-Tian Hu | |||
Na Zheng | |||
Joshua D Rizak | |||
Zheng-Hui Li | |||
Dong-Dong Qin | |||
Mei-Feng Yang | |||
Shi-Hao Wu | |||
Xiao-Bin He | |||
Xia-Ping He | |||
Lin-Heng Zhang | |||
Hen Tang | |||
Zhi-Xing Liao | |||
P2860 | cites work | Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy | Q24535690 |
Altering the tropism of lentiviral vectors through pseudotyping | Q24538987 | ||
Early Parkinson's disease symptoms in α-synuclein transgenic monkeys | Q27301058 | ||
Progress and prospects: immune responses to viral vectors | Q28264531 | ||
In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector | Q29547503 | ||
Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity | Q29615792 | ||
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo | Q29616612 | ||
The development and application of optogenetics | Q29616622 | ||
Stepwise evolution of stable sociality in primates | Q30085655 | ||
Consequences of early adverse rearing experience(EARE) on development: insights from non-human primate studies. | Q30359595 | ||
Lentivirus-based genetic manipulations of cortical neurons and their optical and electrophysiological monitoring in vivo | Q30846112 | ||
Harnessing HIV for therapy, basic research and biotechnology | Q31138752 | ||
The CMV early enhancer/chicken beta actin (CAG) promoter can be used to drive transgene expression during the differentiation of murine embryonic stem cells into vascular progenitors | Q33314424 | ||
Efficient gene delivery and selective transduction of glial cells in the mammalian brain by AAV serotypes isolated from nonhuman primates. | Q33713108 | ||
Comparative transduction efficiency of AAV vector serotypes 1-6 in the substantia nigra and striatum of the primate brain | Q33731226 | ||
Differential transduction following basal ganglia administration of distinct pseudotyped AAV capsid serotypes in nonhuman primates | Q33731243 | ||
Development of a self-inactivating lentivirus vector. | Q33784841 | ||
Gene therapy in the CNS. | Q33837123 | ||
Adeno-associated viral vectors as gene delivery vehicles | Q33941630 | ||
Adeno-associated virus (AAV) serotype 9 provides global cardiac gene transfer superior to AAV1, AAV6, AAV7, and AAV8 in the mouse and rat. | Q34132686 | ||
Immune response following intraocular delivery of recombinant viral vectors | Q34198445 | ||
Selective and rapid uptake of adeno-associated virus type 2 in brain | Q34471578 | ||
Gene delivery by lentivirus vectors | Q34688367 | ||
Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection | Q34770058 | ||
Analysis of transduction efficiency, tropism and axonal transport of AAV serotypes 1, 2, 5, 6, 8 and 9 in the mouse brain | Q35006292 | ||
Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. | Q35111738 | ||
Viral vectors for gene delivery to the nervous system | Q35120134 | ||
Models of Parkinson's disease | Q35158085 | ||
Adeno-associated virus serotype 9 transduction in the central nervous system of nonhuman primates | Q35892068 | ||
Lentivirus-mediated gene transfer to the central nervous system: therapeutic and research applications | Q36366788 | ||
Adeno-associated virus type 12 (AAV12): a novel AAV serotype with sialic acid- and heparan sulfate proteoglycan-independent transduction activity | Q36424146 | ||
Serotype-dependent transduction efficiencies of recombinant adeno-associated viral vectors in monkey neocortex | Q36508670 | ||
The 3'-untranslated region of CaMKII alpha is a cis-acting signal for the localization and translation of mRNA in dendrites | Q36690536 | ||
Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection | Q36720691 | ||
Immune responses to AAV vectors: overcoming barriers to successful gene therapy | Q36983740 | ||
Adeno-associated virus (AAV) gene therapy for neurological disease | Q37998750 | ||
The common marmoset as a novel animal model system for biomedical and neuroscience research applications | Q38032647 | ||
Nuclear import defect of human immunodeficiency virus type 1 DNA flap mutants is not dependent on the viral strain or target cell type | Q38761998 | ||
Opportunities and challenges in modeling human brain disorders in transgenic primates | Q38826903 | ||
Generation of gene-modified cynomolgus monkey via Cas9/RNA-mediated gene targeting in one-cell embryos. | Q39028341 | ||
Gene therapy vectors based on adeno-associated virus type 1. | Q39550492 | ||
Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity | Q39686097 | ||
The human ubiquitin C promoter directs high ubiquitous expression of transgenes in mice | Q39716227 | ||
Lentivirus-mediated expression of glutathione peroxidase: neuroprotection in murine models of Parkinson's disease | Q40397185 | ||
Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models | Q40418515 | ||
Human immunodeficiency virus infection of cells arrested in the cell cycle | Q41531689 | ||
Evaluation of the expression pattern of rAAV2/1, 2/5, 2/7, 2/8, and 2/9 serotypes with different promoters in the mouse visual cortex | Q41716240 | ||
Comparative analyses of adeno-associated viral vector serotypes 1, 2, 5, 8 and 9 in marmoset, mouse and macaque cerebral cortex. | Q42186659 | ||
Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 | ||
Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system. | Q43940212 | ||
Efficient transduction of non-human primate motor neurons after intramuscular delivery of recombinant AAV serotype 6. | Q44852051 | ||
Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system | Q45007196 | ||
Efficient gene transduction of neurons by lentivirus with enhanced neuron-specific promoters. | Q45264367 | ||
Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain | Q45420843 | ||
Human synapsin 1 gene promoter confers highly neuron-specific long-term transgene expression from an adenoviral vector in the adult rat brain depending on the transduced area. | Q45858691 | ||
Comparative analysis of adeno-associated viral vector serotypes 1, 2, 5, 7, and 8 in mouse brain | Q45866495 | ||
Human CMV immediate-early enhancer: a useful tool to enhance cell-type-specific expression from lentiviral vectors | Q45872906 | ||
Autism-like behaviours and germline transmission in transgenic monkeys overexpressing MeCP2. | Q47341079 | ||
Monosialoanglioside improves memory deficits and relieves oxidative stress in the hippocampus of rat model of Alzheimer's disease | Q48258142 | ||
The human ubiquitin C promoter drives selective expression in principal neurons in the brain of a transgenic mouse line | Q48983644 | ||
Gene transfer into the central nervous system in vivo using a recombinanat lentivirus vector. | Q52124625 | ||
Transgenic mouse models of Alzheimer's disease | Q82647986 | ||
P433 | issue | 2 | |
P921 | main subject | rhesus macaque | Q156606 |
P304 | page(s) | 88-95 | |
P577 | publication date | 2017-03-01 | |
P1433 | published in | Zoological Research | Q27714095 |
P1476 | title | Comparative study of the transfection efficiency of commonly used viral vectors in rhesus monkey (Macaca mulatta) brains | |
P478 | volume | 38 |
Q90732125 | AAV Gene Transfer with Tandem Promoter Design Prevents Anti-transgene Immunity and Provides Persistent Efficacy in Neonate Pompe Mice | cites work | P2860 |
Search more.